COMPANY
Artelo Biosciences
Funding and NIH signals
- SEC Form D raise Raised $315K in debt securities (Form D filed Mar 27, 2026); +4 other Form D filings in the last 12 months. SEC Form D 0001621221-26-000004 (Mar 27, 2026)
Evidence (5 events)
- Mar 27, 2026 · SEC Form D 0001621221-26-000004
Name of Issuer: ARTELO BIOSCIENCES, INC.; CIK: 1621221; Address: Solana Beach, CA; Submission type: D; Filing date: 2026-03-27; Industry Group: Biotechnology; Date of First Sale: 2026-03-20; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 315000; Total Amount Sold: 315000; Federal exemptions: 06b - Mar 27, 2026 · SEC Form D 0001621221-26-000003
Name of Issuer: ARTELO BIOSCIENCES, INC.; CIK: 1621221; Address: Solana Beach, CA; Submission type: D; Filing date: 2026-03-27; Industry Group: Biotechnology; Date of First Sale: 2026-03-12; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 113000; Total Amount Sold: 113000; Federal exemptions: 06b - Mar 27, 2026 · SEC Form D 0001621221-26-000002
Name of Issuer: ARTELO BIOSCIENCES, INC.; CIK: 1621221; Address: Solana Beach, CA; Submission type: D; Filing date: 2026-03-27; Industry Group: Biotechnology; Date of First Sale: 2026-03-12; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 237300; Total Amount Sold: 237300; Federal exemptions: 06b - Feb 6, 2026 · SEC Form D 0001621221-26-000001
Name of Issuer: ARTELO BIOSCIENCES, INC.; CIK: 1621221; Address: Solana Beach, CA; Submission type: D; Filing date: 2026-02-06; Industry Group: Biotechnology; Date of First Sale: 2026-01-30; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 50500000; Total Amount Sold: 500000; Federal exemptions: 06b - Nov 10, 2025 · SEC Form D 0001640334-25-001998
Name of Issuer: ARTELO BIOSCIENCES, INC.; CIK: 1621221; Address: Solana Beach, CA; Submission type: D; Filing date: 2025-11-10; Industry Group: Biotechnology; Date of First Sale: 2025-10-28; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3718121; Total Amount Sold: 3718121; Federal exemptions: 06b
- Mar 27, 2026 · SEC Form D 0001621221-26-000004
Timeline
- Raise Private placement: $11M (total, as published), announced Mar 30, 2026. Source: SEC filing. source ↗ · Form D filed Apr 6, 2026 SEC Form D ↗
- Raise Follow-on offering: $2M (total, as published), announced Oct 1, 2025. Source: SEC filing. source ↗
- Raise Follow-on offering: $3M (total, as published), announced Sep 5, 2025. Source: SEC filing. source ↗
Funding
- Private placement: $11M (total, as published), announced Mar 30, 2026. Source: SEC filing. source ↗ · Form D filed Apr 6, 2026 SEC Form D ↗
- Follow-on offering: $2M (total, as published), announced Oct 1, 2025. Source: SEC filing. source ↗
- Follow-on offering: $3M (total, as published), announced Sep 5, 2025. Source: SEC filing. source ↗
Raises and investors new
- Raise Private raise (SEC Form D): $11.0M sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $315K sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $113K sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $237K sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $500K sold of $50.5M offered; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $3.7M sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $9.5M sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗
- Raise Private raise (SEC Form D): $1.4M sold; issuer “ARTELO BIOSCIENCES, INC.”. Verified from the SEC filing. SEC filing ↗